Scinai Immunotherapeutics (SCNI) Non-Current Assets (2017 - 2026)

Scinai Immunotherapeutics has disclosed Non-Current Assets across 10 years of filings, most recently posting $13.7 million for Q2 2026.

• In Q2 2026, Non-Current Assets rose 32.45% year-over-year to $13.7 million; the TTM figure through Jun 2026 stood at $13.7 million (up 32.45% YoY), while the FY2025 annual figure was $9.6 million, down 13.43% from the prior year.
• Non-Current Assets came in at $13.7 million for Q2 2026 at Scinai Immunotherapeutics, down from $14.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $14.0 million in Q1 2026 to a low of $9.6 million in Q4 2025.
• Average Non-Current Assets over 5 years is $11.9 million, with a median of $12.0 million recorded in 2023.
• Year-over-year, Non-Current Assets declined 13.43% in 2025 and surged 32.45% in 2026.
• Over 5 years, Non-Current Assets stood at $12.7 million in 2022, then dropped by 5.29% to $12.0 million in 2023, then declined by 8.05% to $11.1 million in 2024, then decreased by 13.43% to $9.6 million in 2025, then soared by 42.99% to $13.7 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $13.7 million in Q2 2026, $14.0 million in Q1 2026, and $9.6 million in Q4 2025.